Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Mechanisms of Sleep Restriction
NCT02256865Phase 1Completed
- Sponsor
- The Lundquist Institute
- Start
- Oct 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Ketoconazole Cream in insulin resistance (IR) (2 arms), sponsored by The Lundquist Institute. Primary endpoint: Insulin Sensitivity at Day 5. Started Oct 2014; status: completed.
02
Drugs
Ketoconazole Cream
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02256865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256865.